HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-AUG-13 4MCV TITLE STAR 12 BOUND TO ANALOG-SENSITIVE SRC KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SRC KINASE DOMAIN (UNP RESIDUES 256-533); COMPND 5 SYNONYM: PROTO-ONCOGENE C-SRC, PP60C-SRC, P60-SRC; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: BANTAM,CHICKENS; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: SRC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE DOMAIN, TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.S.LOPEZ,K.M.SHOKAT REVDAT 4 28-FEB-24 4MCV 1 REMARK SEQADV REVDAT 3 15-NOV-17 4MCV 1 REMARK REVDAT 2 18-DEC-13 4MCV 1 JRNL REVDAT 1 20-NOV-13 4MCV 0 JRNL AUTH M.S.LOPEZ,J.W.CHOY,U.PETERS,M.L.SOS,D.O.MORGAN,K.M.SHOKAT JRNL TITL STAUROSPORINE-DERIVED INHIBITORS BROADEN THE SCOPE OF JRNL TITL 2 ANALOG-SENSITIVE KINASE TECHNOLOGY. JRNL REF J.AM.CHEM.SOC. V. 135 18153 2013 JRNL REFN ISSN 0002-7863 JRNL PMID 24171479 JRNL DOI 10.1021/JA408704U REMARK 2 REMARK 2 RESOLUTION. 2.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.3_928 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 19330 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.243 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1931 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.5353 - 6.5693 0.99 1284 143 0.2004 0.2356 REMARK 3 2 6.5693 - 5.2170 0.99 1272 140 0.2515 0.2562 REMARK 3 3 5.2170 - 4.5584 0.99 1285 138 0.2056 0.2764 REMARK 3 4 4.5584 - 4.1420 0.99 1272 147 0.2040 0.2772 REMARK 3 5 4.1420 - 3.8453 0.98 1234 137 0.2175 0.2905 REMARK 3 6 3.8453 - 3.6187 0.99 1277 143 0.2413 0.2889 REMARK 3 7 3.6187 - 3.4375 0.99 1284 143 0.2424 0.2717 REMARK 3 8 3.4375 - 3.2879 0.98 1250 140 0.2497 0.3010 REMARK 3 9 3.2879 - 3.1614 0.98 1270 144 0.2593 0.2956 REMARK 3 10 3.1614 - 3.0523 0.98 1249 134 0.2771 0.3191 REMARK 3 11 3.0523 - 2.9569 0.99 1304 141 0.2863 0.3658 REMARK 3 12 2.9569 - 2.8724 0.98 1254 138 0.2952 0.3861 REMARK 3 13 2.8724 - 2.7968 0.98 1257 140 0.3044 0.3722 REMARK 3 14 2.7968 - 2.7300 0.71 907 103 0.3374 0.3876 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.73 REMARK 3 K_SOL : 0.31 REMARK 3 B_SOL : 22.67 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.33 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.50590 REMARK 3 B22 (A**2) : -5.53010 REMARK 3 B33 (A**2) : 11.03600 REMARK 3 B12 (A**2) : -1.87820 REMARK 3 B13 (A**2) : -0.96180 REMARK 3 B23 (A**2) : -8.90350 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4398 REMARK 3 ANGLE : 0.668 5974 REMARK 3 CHIRALITY : 0.048 638 REMARK 3 PLANARITY : 0.002 754 REMARK 3 DIHEDRAL : 11.401 1629 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MCV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081751. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19330 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.730 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 1.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.3.0 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG, 50 MM NAOAC, 100 MM MES, PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 ALA B 256 REMARK 465 GLY B 300 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 GLU A 265 CG CD OE1 OE2 REMARK 470 SER A 266 OG REMARK 470 ARG A 268 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 331 CG CD OE1 OE2 REMARK 470 LEU A 407 CG CD1 CD2 REMARK 470 GLU A 412 CG CD OE1 OE2 REMARK 470 PHE A 424 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 257 CG CD CE NZ REMARK 470 SER B 303 OG REMARK 470 GLU B 305 CG CD OE1 OE2 REMARK 470 GLN B 309 CG CD OE1 NE2 REMARK 470 GLU B 310 CG CD OE1 OE2 REMARK 470 GLU B 331 CG CD OE1 OE2 REMARK 470 ARG B 409 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 423 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 527 OXT LEU B 533 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 270 -69.57 -122.73 REMARK 500 THR A 289 -41.40 -142.52 REMARK 500 SER A 303 83.71 62.45 REMARK 500 ARG A 385 -0.39 68.11 REMARK 500 ASP A 386 53.20 -157.91 REMARK 500 ASP A 404 90.62 57.49 REMARK 500 PHE A 405 64.22 -111.94 REMARK 500 LEU A 407 19.42 58.91 REMARK 500 ARG A 409 -159.94 -130.82 REMARK 500 LEU A 410 -166.35 -75.22 REMARK 500 TYR A 463 73.17 54.17 REMARK 500 GLU A 486 -8.32 65.02 REMARK 500 GLU B 270 -74.89 -118.38 REMARK 500 PHE B 278 -17.94 -140.77 REMARK 500 SER B 303 77.66 65.55 REMARK 500 GLU B 305 33.33 -91.87 REMARK 500 ASP B 386 58.15 -115.96 REMARK 500 ALA B 403 -91.71 -111.05 REMARK 500 ASP B 404 101.39 -54.53 REMARK 500 PRO B 425 93.43 -67.37 REMARK 500 GLN B 526 42.92 -107.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 29K A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 29K B 601 DBREF 4MCV A 256 533 UNP P00523 SRC_CHICK 256 533 DBREF 4MCV B 256 533 UNP P00523 SRC_CHICK 256 533 SEQADV 4MCV GLY A 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQADV 4MCV GLY B 338 UNP P00523 THR 338 ENGINEERED MUTATION SEQRES 1 A 278 ALA LYS ASP ALA TRP GLU ILE PRO ARG GLU SER LEU ARG SEQRES 2 A 278 LEU GLU VAL LYS LEU GLY GLN GLY CYS PHE GLY GLU VAL SEQRES 3 A 278 TRP MET GLY THR TRP ASN GLY THR THR ARG VAL ALA ILE SEQRES 4 A 278 LYS THR LEU LYS PRO GLY THR MET SER PRO GLU ALA PHE SEQRES 5 A 278 LEU GLN GLU ALA GLN VAL MET LYS LYS LEU ARG HIS GLU SEQRES 6 A 278 LYS LEU VAL GLN LEU TYR ALA VAL VAL SER GLU GLU PRO SEQRES 7 A 278 ILE TYR ILE VAL GLY GLU TYR MET SER LYS GLY SER LEU SEQRES 8 A 278 LEU ASP PHE LEU LYS GLY GLU MET GLY LYS TYR LEU ARG SEQRES 9 A 278 LEU PRO GLN LEU VAL ASP MET ALA ALA GLN ILE ALA SER SEQRES 10 A 278 GLY MET ALA TYR VAL GLU ARG MET ASN TYR VAL HIS ARG SEQRES 11 A 278 ASP LEU ARG ALA ALA ASN ILE LEU VAL GLY GLU ASN LEU SEQRES 12 A 278 VAL CYS LYS VAL ALA ASP PHE GLY LEU ALA ARG LEU ILE SEQRES 13 A 278 GLU ASP ASN GLU TYR THR ALA ARG GLN GLY ALA LYS PHE SEQRES 14 A 278 PRO ILE LYS TRP THR ALA PRO GLU ALA ALA LEU TYR GLY SEQRES 15 A 278 ARG PHE THR ILE LYS SER ASP VAL TRP SER PHE GLY ILE SEQRES 16 A 278 LEU LEU THR GLU LEU THR THR LYS GLY ARG VAL PRO TYR SEQRES 17 A 278 PRO GLY MET VAL ASN ARG GLU VAL LEU ASP GLN VAL GLU SEQRES 18 A 278 ARG GLY TYR ARG MET PRO CYS PRO PRO GLU CYS PRO GLU SEQRES 19 A 278 SER LEU HIS ASP LEU MET CYS GLN CYS TRP ARG LYS ASP SEQRES 20 A 278 PRO GLU GLU ARG PRO THR PHE GLU TYR LEU GLN ALA PHE SEQRES 21 A 278 LEU GLU ASP TYR PHE THR SER THR GLU PRO GLN TYR GLN SEQRES 22 A 278 PRO GLY GLU ASN LEU SEQRES 1 B 278 ALA LYS ASP ALA TRP GLU ILE PRO ARG GLU SER LEU ARG SEQRES 2 B 278 LEU GLU VAL LYS LEU GLY GLN GLY CYS PHE GLY GLU VAL SEQRES 3 B 278 TRP MET GLY THR TRP ASN GLY THR THR ARG VAL ALA ILE SEQRES 4 B 278 LYS THR LEU LYS PRO GLY THR MET SER PRO GLU ALA PHE SEQRES 5 B 278 LEU GLN GLU ALA GLN VAL MET LYS LYS LEU ARG HIS GLU SEQRES 6 B 278 LYS LEU VAL GLN LEU TYR ALA VAL VAL SER GLU GLU PRO SEQRES 7 B 278 ILE TYR ILE VAL GLY GLU TYR MET SER LYS GLY SER LEU SEQRES 8 B 278 LEU ASP PHE LEU LYS GLY GLU MET GLY LYS TYR LEU ARG SEQRES 9 B 278 LEU PRO GLN LEU VAL ASP MET ALA ALA GLN ILE ALA SER SEQRES 10 B 278 GLY MET ALA TYR VAL GLU ARG MET ASN TYR VAL HIS ARG SEQRES 11 B 278 ASP LEU ARG ALA ALA ASN ILE LEU VAL GLY GLU ASN LEU SEQRES 12 B 278 VAL CYS LYS VAL ALA ASP PHE GLY LEU ALA ARG LEU ILE SEQRES 13 B 278 GLU ASP ASN GLU TYR THR ALA ARG GLN GLY ALA LYS PHE SEQRES 14 B 278 PRO ILE LYS TRP THR ALA PRO GLU ALA ALA LEU TYR GLY SEQRES 15 B 278 ARG PHE THR ILE LYS SER ASP VAL TRP SER PHE GLY ILE SEQRES 16 B 278 LEU LEU THR GLU LEU THR THR LYS GLY ARG VAL PRO TYR SEQRES 17 B 278 PRO GLY MET VAL ASN ARG GLU VAL LEU ASP GLN VAL GLU SEQRES 18 B 278 ARG GLY TYR ARG MET PRO CYS PRO PRO GLU CYS PRO GLU SEQRES 19 B 278 SER LEU HIS ASP LEU MET CYS GLN CYS TRP ARG LYS ASP SEQRES 20 B 278 PRO GLU GLU ARG PRO THR PHE GLU TYR LEU GLN ALA PHE SEQRES 21 B 278 LEU GLU ASP TYR PHE THR SER THR GLU PRO GLN TYR GLN SEQRES 22 B 278 PRO GLY GLU ASN LEU HET 29K A 601 33 HET 29K B 601 33 HETNAM 29K (7S)-12-(4-AMINOBUTYL)-7-(2-METHYLPROPYL)-6,7,12,13- HETNAM 2 29K TETRAHYDRO-5H-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-5- HETNAM 3 29K ONE FORMUL 3 29K 2(C28 H30 N4 O) HELIX 1 1 PRO A 263 GLU A 265 5 3 HELIX 2 2 LEU A 308 LEU A 317 1 10 HELIX 3 3 SER A 345 GLY A 352 1 8 HELIX 4 4 GLU A 353 TYR A 357 5 5 HELIX 5 5 ARG A 359 MET A 380 1 22 HELIX 6 6 ARG A 388 ALA A 390 5 3 HELIX 7 7 GLU A 396 LEU A 398 5 3 HELIX 8 8 ALA A 430 TYR A 436 1 7 HELIX 9 9 THR A 440 THR A 457 1 18 HELIX 10 10 VAL A 467 GLY A 478 1 12 HELIX 11 11 PRO A 488 TRP A 499 1 12 HELIX 12 12 ASP A 502 ARG A 506 5 5 HELIX 13 13 THR A 508 ASP A 518 1 11 HELIX 14 14 ASP A 518 THR A 523 1 6 HELIX 15 15 PRO B 263 GLU B 265 5 3 HELIX 16 16 SER B 345 GLY B 352 1 8 HELIX 17 17 GLU B 353 LEU B 358 5 6 HELIX 18 18 ARG B 359 MET B 380 1 22 HELIX 19 19 ARG B 388 ALA B 390 5 3 HELIX 20 20 GLU B 396 LEU B 398 5 3 HELIX 21 21 ALA B 430 TYR B 436 1 7 HELIX 22 22 THR B 440 THR B 456 1 17 HELIX 23 23 VAL B 467 GLY B 478 1 12 HELIX 24 24 PRO B 488 TRP B 499 1 12 HELIX 25 25 ASP B 502 ARG B 506 5 5 HELIX 26 26 THR B 508 ASP B 518 1 11 HELIX 27 27 ASP B 518 THR B 523 1 6 SHEET 1 A 5 LEU A 267 GLN A 275 0 SHEET 2 A 5 GLU A 280 TRP A 286 -1 O VAL A 281 N LEU A 273 SHEET 3 A 5 THR A 290 LYS A 295 -1 O THR A 290 N TRP A 286 SHEET 4 A 5 TYR A 335 GLY A 338 -1 O ILE A 336 N LYS A 295 SHEET 5 A 5 LEU A 325 VAL A 329 -1 N ALA A 327 O VAL A 337 SHEET 1 B 2 ILE A 392 VAL A 394 0 SHEET 2 B 2 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 C 5 LEU B 267 GLN B 275 0 SHEET 2 C 5 GLU B 280 TRP B 286 -1 O VAL B 281 N LEU B 273 SHEET 3 C 5 THR B 290 LYS B 295 -1 O ILE B 294 N TRP B 282 SHEET 4 C 5 TYR B 335 GLY B 338 -1 O ILE B 336 N LYS B 295 SHEET 5 C 5 LEU B 325 VAL B 329 -1 N TYR B 326 O VAL B 337 SHEET 1 D 2 ILE B 392 VAL B 394 0 SHEET 2 D 2 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 CISPEP 1 PRO A 299 GLY A 300 0 2.33 CISPEP 2 MET A 302 SER A 303 0 11.17 CISPEP 3 GLU A 305 ALA A 306 0 3.59 CISPEP 4 GLU A 332 PRO A 333 0 -1.87 CISPEP 5 MET B 302 SER B 303 0 4.21 CISPEP 6 PRO B 304 GLU B 305 0 3.25 CISPEP 7 GLU B 332 PRO B 333 0 2.19 SITE 1 AC1 12 LEU A 273 ALA A 293 LYS A 295 VAL A 323 SITE 2 AC1 12 GLY A 338 GLU A 339 TYR A 340 MET A 341 SITE 3 AC1 12 GLY A 344 ALA A 390 ASN A 391 LEU A 393 SITE 1 AC2 12 LEU B 273 ALA B 293 LYS B 295 VAL B 323 SITE 2 AC2 12 GLY B 338 GLU B 339 TYR B 340 MET B 341 SITE 3 AC2 12 GLY B 344 ALA B 390 ASN B 391 LEU B 393 CRYST1 42.342 63.344 73.618 100.34 90.81 89.95 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023617 -0.000019 0.000334 0.00000 SCALE2 0.000000 0.015787 0.002880 0.00000 SCALE3 0.000000 0.000000 0.013809 0.00000